₹748.00 Crores | Listing at BSE, NSE | Tue, Mar 15, 2022 - Tue, Mar 22, 2022
Wockhardt Ltd Rights Issue comprises 3.32 Cr equity shares aggregating to ₹748.00 Cr, offered at an issue price of ₹225 per share with a face value of ₹5 per share.
The record date for determining eligible shareholders is Mar 9, 2022.
As per the terms of payment, ₹225 per share payable in full at the time of application.
The Rights Entitlements are expected to be credited to eligible demat accounts on Mar 11, 2022.
The Rights Issue opens on Mar 15, 2022, and closes on Mar 22, 2022, with renunciation of Rights Entitlements permitted up to Mar 16, 2022.
The deemed date of allotment is Mar 30, 2022, following which the equity shares are expected to be credited to demat accounts on Apr 1, 2022 and listed on NSE and BSE on Apr 4, 2022.
Ambit Pvt.Ltd. is the Lead Manager to the issue and MUFG Intime India Pvt.Ltd. is the Registrar to the Issue.
Investors are advised to refer to the Wockhardt Ltd Letter of Offer for detailed information, including risk factors, issue terms, and procedural details.
Record Date
Wed, Mar 9, 2022
Entitlement Ratio
:
Open Date
Tue, Mar 15, 2022
Close Date
Tue, Mar 22, 2022
| Particulars | For the year/period ended (Rs.in Cr) | ||
|---|---|---|---|
| 30-Sep-21 | 31-Mar-21 | ||
| Total Assets | 8,009.18 | 7,772.69 | |
| Total Income | 867.20 | 2,840.57 | |
| Profit After Tax | 37.17 | 688.60 | |
Wockhardt is a global pharmaceutical and biotechnology organization that offers affordable high quality medicines. It is India's leading global research-based global healthcare company in the field of Biotechnology, Pharmaceuticals, and advanced Super Speciality Hospitals. It manufactures and market Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs), and Vaccines. Currently, the business has 12 manufacturing facilities and 3 research centres.
The company aims to utilize the proceed from the right issue for the following purposes;
[Dilip Davda] The company has worldwide operations, but of late it has been posting losses and has skipped dividends from FY17. The counters have seen price movements well above the RI pricing and makes this offer a worthy bet. Investors may consider investing in this fully priced offer with a long term perspective. Read detail review...
Wockhardt Ltd
Wockhardt Towers, Bandra-Kurla Complex
Bandra East, Mumbai 400 051
The Wockhardt Rights Issue opens on Tue, Mar 15, 2022, and closes on Tue, Mar 22, 2022.
Wockhardt Rights Issue Schedule
| Last Date for credit of Rights Entitlements | Fri, Mar 11, 2022 |
| Last Date for renunciation of Rights Entitlements | Wed, Mar 16, 2022 |
| Issue Opening Date | Tue, Mar 15, 2022 |
| Issue Closing Date | Tue, Mar 22, 2022 |
| Date of Allotment (on or about) | Wed, Mar 30, 2022 |
| Date of Credit (on or about) | Fri, Apr 1, 2022 |
| Date of Listing (on or about) | Mon, Apr 4, 2022 |
You can apply for Wockhardt Rights Issue in two ways:
Steps to apply for Wockhardt Rights Issue using Net Banking (ASBA)
Steps to apply for Wockhardt Rights Issue using Registrar's website (R-WAP)
